Funded Startups in Hanover
Across the 20 most recent rounds listed for Hanover, one disclosed deal dwarfs the rest: Dragos’ $200M Series D (2021-10-28).
Across the 20 most recent rounds listed for Hanover, one disclosed deal dwarfs the rest: Dragos’ $200M Series D (2021-10-28). The next tier of disclosed rounds sits far lower, with several deals in the $75M–$40M range (Cardior Pharmaceuticals $75M on 2021-08-25; Better Life Partners $27M on 2023-08-29; Maribel Health $25M on 2023-03-15; Processa/other nearby listings are undisclosed), making Dragos an outlier by disclosed size.
Timing and geography cluster as well. The rounds span 2021-02-01 (iotis) through 2025-09-09 (Noxilizer), and a notable concentration occurs in 2022–2023 for Hannover, Niedersachsen entries (e.g., Wingfield $4M on 2022-06-06; Cardior Pharmaceuticals $75M on 2021-08-25; Hornetsecurity is undisclosed on 2022-09-06), while Hanover, Maryland appears in separate pockets (Dragos $200M on 2021-10-28; BTE Technologies $40K on 2025-02-19; Processa Pharmaceuticals is undisclosed on 2025-08-07). A large share of rounds also lack disclosed amounts: 6 entries are undisclosed/“undisclosed” and 2 are “disclosed amount” missing via blank amount, so only the remaining rows contribute to size comparisons (e.g., Noxilizer $30M on 2025-09-09 is the most recent disclosed amount).
Most recent rounds
20 shownRelated listings
Frequently asked
Which disclosed round is the size outlier among the Hanover listings, and how extreme is it vs. the next-largest disclosed amounts?
Dragos’ disclosed $200M (Series D, 2021-10-28) is the clear outlier; the next-largest disclosed amount is Cardior Pharmaceuticals at $75M (Series B, 2021-08-25), with no other disclosed round above $40M in the shown rows (e.g., Noxilizer $30M on 2025-09-09).
How do the recent rounds cluster by date in the last few months shown?
Only two entries fall in the last ~90 days of the list window: Noxilizer $30M on 2025-09-09 and Papair (undisclosed) on 2025-08-25, plus Processa Pharmaceuticals (undisclosed) on 2025-08-07. The next most recent disclosed amount after those appears much earlier, such as BTE Technologies $40K on 2025-02-19.
Is one geography more represented than others, or are there distinct Hanover variants?
The dataset splits across Hanover, Niedersachsen (Germany) and Hanover, New Hampshire/United States, with Hanover, Maryland (United States) appearing separately. For example, Hanover, Niedersachsen includes Cardior Pharmaceuticals ($75M, 2021-08-25) and Hornetsecurity (undisclosed, 2022-09-06), while Hanover, Maryland includes Dragos ($200M, 2021-10-28) and BTE Technologies ($40K, 2025-02-19).
What stage mix dominates the disclosed rounds, and what stages appear only via undisclosed amounts?
Across the rows, Seed and later named series show up repeatedly: Better Life Partners is Series B ($27M, 2023-08-29), Maribel Health is Series A ($25M, 2023-03-15), and Wingfield is Series A ($4M, 2022-06-06). At the same time, several recent and older entries use “Series Unknown” or show undisclosed amounts (e.g., Papair on 2025-08-25 and Processa Pharmaceuticals on 2025-08-07), limiting stage-to-size inference for those companies.
How common are undisclosed/blank amounts, and does that affect identifying the largest/smallest rounds?
6 rows explicitly show “undisclosed” amounts, and 2 additional rows have blank amount values, meaning 8 of 20 cannot be used for disclosed-size comparisons. Among disclosed amounts only, Vays is the smallest at $100K (Seed, 2022-03-23) while Dragos’ $200M remains the largest (Series D, 2021-10-28).
Which sector shows up most often in this Hanover slice, and how does that relate to the biggest disclosed deals?
Biotechnology appears in at least four entries: Processa Pharmaceuticals (undisclosed, 2025-08-07), Terragia Biofuel ($6M, 2024-03-28), Cardior Pharmaceuticals ($75M, 2021-08-25), and Dragos (Information Technology is listed, but Cardior is the biotech anchor here; additionally iotis is “Other,” not biotech). The largest disclosed biotech-linked deal is Cardior Pharmaceuticals at $75M (2021-08-25), while the overall disclosed size outlier (Dragos $200M) is categorized as Information Technology.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.